| MolName | (2R,4S)-5-[(3S,5R)-3,5-dibenzyl-2-oxopyrrolidin-1-yl]-4-hydroxy-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2-[[4-(2-morpholin-4-ylethoxy)phenyl]methyl]pentanamide |
| MolecularFormula | C45H53N3O6 |
| Smiles | O[C@@H](C[C@@H](Cc(cc1)ccc1OCCN1CCOCC1)C(N[C@H]([C@@H](C1)O)c2c1cccc2)=O)CN([C@@H](Cc1ccccc1)C[C@@H]1Cc2ccccc2)C1=O |
| InChI | InChI=1S/C45H53N3O6/c49-39(31-48-38(27-33-11-5-2-6-12-33)28-37(45(48)52)26-32-9-3-1-4-10-32)29-36(44(51)46-43-41-14-8-7-13-35(41)30-42(43)50)25-34-15-17-40(18-16-34)54-24-21-47-19-22-53-23-20-47/h1-18,36-39,42-43,49-50H,19-31H2,(H,46,51)/t36-,37+,38-,39+, |
| InChIK | LXCFLCBSDJGXNU-VPISVCLZSA-N |
| TotalMolweight | 731.931 |
| Molweight | 731.931 |
| MonoisotopicMass | 731.393437 |
| CLogP | 5.5032 |
| CLogS | -5.578 |
| H Acceptors | 9 |
| H Donors | 3 |
| TotalSurfaceArea | 566.18 |
| Relative PSA | 0.16044 |
| PolarSurfaceArea | 111.57 |
| Druglikeness | 5.6832 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | |
| Shape Index | 0.44444 |
| Fragments | 1 |
| Non HAtoms | 54 |
| NonCHAtoms | 9 |
| Electronegative Atoms | 9 |
| StereoCenters | 6 |
| Rotatable Bond | 16 |
| Rings Closures | 7 |
| Small Rings | 7 |
| Aromatic Rings | 4 |
| Aromatic Atoms | 24 |
| Sp3Atoms | 24 |
| Symmetricatoms | 8 |
| Amides | 2 |
| Amines | 1 |
| AlkylAmines | 1 |
| BasicNitrogens | 1 |
| StereoCon | this enantiomer |
Click to Load Molecule:
1 - (2R,4S)-5-[(3S,5R)-3,5-dibenzyl-2-oxopyrrolidin-1-yl]-4-hydroxy-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2-[[4-(2-morpholin-4-ylethoxy)phenyl]methyl]pentanamide | 2 - (2R,4S)-5-[(3S,5R)-3,5-dibenzyl-2-oxopyrrolidin-1-yl]-4-hydroxy-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2-[[4-(2-morpholin-4-ylethoxy)phenyl]methyl]pentanamide